|
|
|
Insider
Information: |
Chalmers Derek T |
Relationship: |
President & CEO, Direc... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
1,362,072 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$37,699,574 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,362,072 |
|
|
Total
Value |
$37,699,574 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
-39.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Arena Pharmaceuticals Inc |
ARNA |
Former VP, Research an... |
2004-06-11 |
370,667 |
2004-06-11 |
0 |
Premium* |
|
Cara Therapeutics, Inc. |
CARA |
President & CEO, Direc... |
2021-09-07 |
991,405 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2019-01-04 |
4 |
AS |
$15.04 |
$75,200 |
D/D |
(5,000) |
973,788 |
0 |
- |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2017-07-14 |
4 |
AS |
$15.05 |
$376,250 |
D/D |
(25,000) |
1,082,292 |
0 |
- |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-12-10 |
4 |
S |
$15.29 |
$114,675 |
D/D |
(7,500) |
933,921 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-12-30 |
4 |
AS |
$15.30 |
$92,993 |
D/D |
(6,078) |
936,593 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2021-09-07 |
4 |
S |
$15.47 |
$309,400 |
D/D |
(20,000) |
991,405 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-04-21 |
4 |
AS |
$15.56 |
$98,775 |
D/D |
(6,348) |
981,421 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-05-12 |
4 |
AS |
$16.00 |
$78,864 |
D/D |
(4,929) |
976,492 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-05-20 |
4 |
AS |
$16.00 |
$19,200 |
D/D |
(1,200) |
975,292 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-05-21 |
4 |
AS |
$16.00 |
$56,000 |
D/D |
(3,500) |
971,792 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-05-22 |
4 |
AS |
$16.00 |
$5,936 |
D/D |
(371) |
971,421 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-06-01 |
4 |
AS |
$16.00 |
$11,200 |
D/D |
(700) |
970,721 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-09-03 |
4 |
AS |
$16.00 |
$51,216 |
D/D |
(3,201) |
953,220 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-11-17 |
4 |
AS |
$16.00 |
$188,784 |
D/D |
(11,799) |
941,421 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-12-28 |
4 |
AS |
$16.00 |
$80,000 |
D/D |
(5,000) |
942,671 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-06-03 |
4 |
AS |
$16.01 |
$68,843 |
D/D |
(4,300) |
966,421 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-01-02 |
4 |
AS |
$16.05 |
$160,500 |
D/D |
(10,000) |
917,769 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-08-03 |
4 |
AS |
$16.42 |
$82,100 |
D/D |
(5,000) |
956,421 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2019-03-01 |
4 |
AS |
$17.04 |
$166,856 |
D/D |
(9,792) |
943,996 |
0 |
- |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2019-12-04 |
4 |
AS |
$17.05 |
$182,418 |
D/D |
(10,699) |
927,769 |
0 |
- |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2020-07-01 |
4 |
AS |
$17.11 |
$85,550 |
D/D |
(5,000) |
961,421 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2016-01-06 |
4 |
AS |
$17.22 |
$215,250 |
D/D |
(12,500) |
1,087,292 |
0 |
- |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2021-03-05 |
4 |
AS |
$17.98 |
$55,792 |
D/D |
(3,103) |
950,511 |
0 |
% |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2018-12-03 |
4 |
AS |
$18.17 |
$363,400 |
D/D |
(20,000) |
971,392 |
0 |
- |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2019-10-01 |
4 |
AS |
$18.28 |
$182,800 |
D/D |
(10,000) |
933,468 |
0 |
- |
|
CARA |
Cara Therapeutics, Inc. |
President & CEO |
|
2018-11-01 |
4 |
AS |
$18.78 |
$375,600 |
D/D |
(20,000) |
991,392 |
0 |
- |
|
59 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|